-5.49%

Dow Jones

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ARWR Arrowhead Pharmaceuticals Inc

12.10

-0.59 (-4.65%)

Apr 04 2025 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

01/04/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

03/08/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Patrick O'Brien